These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 3435316

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: observations on regulation of serum calcium.
    van Breukelen FJ, Bijvoet OL, Frijlink WB, Sleeboom HP, Mulder H, van Oosterom AT.
    Calcif Tissue Int; 1982 Jul; 34(4):321-7. PubMed ID: 6814719
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Oral versus intravenous AHPrBP (APD) in the treatment of hypercalcemia of malignancy.
    Thiébaud D, Portmann L, Jaeger P, Jacquet AF, Burckhardt P.
    Bone; 1986 Jul; 7(4):247-53. PubMed ID: 3768203
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Randomized, double-blind, phase II trial of gallium nitrate compared with pamidronate for acute control of cancer-related hypercalcemia.
    Cvitkovic F, Armand JP, Tubiana-Hulin M, Rossi JF, Warrell RP.
    Cancer J; 2006 Jul; 12(1):47-53. PubMed ID: 16613662
    [Abstract] [Full Text] [Related]

  • 32. Dose/response study of aminohydroxypropylidene bisphosphonate in tumor-associated hypercalcemia.
    Body JJ, Pot M, Borkowski A, Sculier JP, Klastersky J.
    Am J Med; 1987 May; 82(5):957-63. PubMed ID: 3578365
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Pamidronate in the treatment of tumor-associated hypercalcemia].
    Pecherstorfer M, Janisch S, Marosi C, Wogritsch C, Bosse C, Schratzberger W, Gerber E, Fortelny A, Lenzhofer R, Rainer H.
    Klin Wochenschr; 1991 Oct 02; 69(15):690-5. PubMed ID: 1795492
    [Abstract] [Full Text] [Related]

  • 37. A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.
    Purohit OP, Radstone CR, Anthony C, Kanis JA, Coleman RE.
    Br J Cancer; 1995 Nov 02; 72(5):1289-93. PubMed ID: 7577484
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Medical treatment of malignant hypercalcemia].
    Eto S, Nakano Y, Okada Y.
    Gan To Kagaku Ryoho; 1993 Dec 02; 20(15):2311-8. PubMed ID: 8259844
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.